BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35431584)

  • 21. Hidradenitis suppurativa, introduction.
    Naik HB
    Semin Cutan Med Surg; 2017 Jun; 36(2):41. PubMed ID: 28538741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
    Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
    Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.
    Nomura T
    Front Immunol; 2020; 11():847. PubMed ID: 32508815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An atlas of the morphological manifestations of hidradenitis suppurativa.
    Scheinfeld N
    Dermatol Online J; 2014 Apr; 20(4):22373. PubMed ID: 24746309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report.
    McKenzie SA; Ni CS; Hsiao JL
    Cureus; 2019 Jun; 11(6):e4970. PubMed ID: 31453042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
    Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
    Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the Management of Perianal Hidradenitis Suppurativa in an African American Male: A Case Report.
    Russell N; Kpughur-Tule N; Ravichandar E; Dorta Torres G; Tiesenga F
    Cureus; 2023 Sep; 15(9):e45788. PubMed ID: 37872932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervicofacial hidradenitis suppurativa: A case report and literature review.
    Francois K; Moon HS; Panchal N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):e25-e31. PubMed ID: 36241598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral Breast Skin Changes in Patient With Hidradenitis Suppurativa: Malignancy Versus Lymphedema.
    Ederle A; Dreher K; Valdes-Rodriguez R
    Cureus; 2021 Jul; 13(7):e16232. PubMed ID: 34367830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
    Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.
    Fotiadou C; Vakirlis E; Ioannides D
    Clin Cosmet Investig Dermatol; 2016; 9():367-372. PubMed ID: 27799806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidradenitis suppurativa at the knees.
    Gosnell HL; Sharghi K; Pickard C; Grider DJ
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
    Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Narla S; Azzam M; Townsend S; Vellaichamy G; Marzano AV; Alavi A; Lowes MA; Hamzavi IH
    Br J Dermatol; 2021 Jun; 184(6):1004-1013. PubMed ID: 32893875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Painful hidradenitis suppurativa.
    Smith HS; Chao JD; Teitelbaum J
    Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special considerations for women with hidradenitis suppurativa.
    Collier E; Shi VY; Parvataneni RK; Lowes MA; Hsiao JL
    Int J Womens Dermatol; 2020 Mar; 6(2):85-88. PubMed ID: 32258337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa.
    Molinelli E; Sapigni C; D'Agostino GM; Brisigotti V; Rizzetto G; Bobyr I; Cirioni O; Giacometti A; Brescini L; Mazzanti S; Offidani A; Simonetti O
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.